Patent · US Active

IDO inhibitors

US9895330B2 · kind B2 · utility

1Cited by

0References

10Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Jay A. Markwalder · New London, US
James Aaron Balog · Lambertville, US
Audris Huang · Princeton, US
Steven P. Seitz · Swarthmore, US

Key dates

Filing date	Jul 10, 2014
Grant date	Feb 20, 2018
Priority date	—
Expiry date	Jul 10, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There are disclosed compounds of Formula (I) that modulate or inhibit the enzymatic activity of indoleamine 2,3-di-oxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, viral infections and/or autoimmune diseases utilizing the compounds of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.